---

For any questions please send e-mail to: NDSU.Policy.Manual@ndsu.edu

---

SECTION 347: INSTITUTIONAL BIOSAFETY COMMITTEE

SOURCE: NDSU President

1. The National Institute of Health (NIH) Guidelines require that each institution conducting or sponsoring recombinant DNA research is responsible for ensuring that research is conducted in accordance with NIH Guidelines. In addition, institutions must establish an Institutional Biosafety Committee (IBC) composed of no fewer than five members collectively having experience and expertise in recombinant DNA research.
   
   North Dakota State University endorses this regulation and has an established Institutional Biosafety Committee. The NDSU IBC's purpose is to assure the safe use of recombinant DNA, infectious agents, and human blood, bodily fluids, or tissues, in research and teaching, and to maintain compliance with NIH Guidelines and additional federal regulations.
   
   
2. All project directors of research and teachers of courses involving recombinant DNA, infectious agents, or human blood, bodily fluids or tissue at NDSU, or conducted by representatives of NDSU, are responsible for submitting the protocol forms required for review and approval by the NDSU Institutional Biosafety Committee.
   
   
3. Further information about the IBC can be obtained from the Office of Sponsored Programs Administration (Old Main 201K, phone: 701-231-8908, email: ndsu_research@ndsu.nodak.edu) .
   
   The NDSU Institutional Biosafety Committee is administered by the Office of Sponsored Programs Administration (Division of the Vice President for Research, Creative Activities and Technology Transfer).

HISTORY: July 31, 2001